Analytics, not advice. Rankings and scores describe past performance and are not recommendations.
Uncategorised
Aditya Birla Sun Life Pharma and Healthcare Fund-Direct-Growth
Aditya Birla Sun Life Mutual Fund · Managed by Dhaval Shah
96strong
Latest NAV
₹40.7600
as of 18 Aug 2026
AUM
—
Expense ratio
0.82%
as of 30 Jun 2026
Inception
14 May 2026
FundScore
96/100strong
Rank #42 of 1015 · top 4%
A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.
Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
3.22%
3M
9.01%
6M
19.39%
1Y
17.13%
3Y CAGR
22.45%
5Y CAGR
14.86%
Since incep.
21.77%
Fund details
- Fund manager
- Dhaval Shah
- Riskometer
- Very High Risk
- Type
- Open Ended
- Portfolio turnover
- 22%
- Volatility (3Y)
- 15.1%
- Rating (external)
- —
Investment objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.
Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.
Pro
Stock holdings
Latest portfolio disclosure for this scheme.
No data yet
This fund hasn't disclosed a portfolio snapshot yet.